ebola
ebov
marburg
viru
marv
caus
sever
hemorrhag
fever
host
cell
proteas
cathepsin
b
l
activ
zair
ebolaviru
glycoprotein
gp
cellular
entri
constitut
potenti
target
antivir
intervent
howev
unclear
differ
ebov
speci
marv
equal
depend
cathepsin
bl
activ
infect
cell
line
macrophag
import
viral
target
cell
show
cathepsin
bl
inhibitor
markedli
reduc
cell
infect
driven
gp
ebov
speci
independ
type
ii
transmembran
serin
proteas
cleav
fail
activ
ebovgp
similarli
cathepsin
bl
inhibitor
block
macrophag
infect
mediat
differ
ebovgp
contrast
marvgpdriven
entri
exhibit
littl
depend
cathepsin
bl
activ
still
marvgpmedi
entri
effici
block
leupeptin
result
suggest
cathepsin
bl
promot
entri
ebov
marv
might
employ
far
unidentifi
proteas
gp
activ
ebola
viru
ebov
marburg
viru
marv
neg
strand
rna
virus
filovirida
famili
caus
sever
hemorrhag
fever
human
singl
speci
marv
lake
victoria
marburgviru
identifi
hartman
et
al
ebov
separ
four
speci
zair
ebolaviru
zebov
sudan
ebolaviru
sebov
cote
divoir
ebolaviru
ciebov
reston
ebolaviru
rebov
feldmann
geisbert
hartman
et
al
fifth
speci
bundibugyo
ebolaviru
bebov
propos
towner
et
al
outbreak
zebov
sebov
ciebov
bebov
marv
occur
sporad
africa
associ
casefat
rate
contrast
rebov
detect
pig
philippin
seem
apathogen
human
feldmann
geisbert
hartman
et
al
ebov
marv
bear
singl
glycoprotein
gp
envelop
mediat
infecti
viral
entri
host
cell
constitut
import
target
prevent
therapi
mani
glycoprotein
relat
ebovgp
like
hiv
envelop
protein
env
synthes
inact
precursor
protein
constitut
secretori
pathway
infect
cell
requir
activ
host
cell
proteas
transit
activ
form
bertram
et
al
ebovgp
hiv
env
cleav
furin
golgi
apparatu
infect
cell
hallenberg
et
al
volchkov
et
al
cleavag
furin
consensu
site
essenti
hiv
infect
mccune
et
al
contrast
gp
cleavag
furin
dispens
ebov
spread
cell
cultur
anim
neumann
et
al
neumann
et
al
woollewi
bate
indic
furin
activ
gp
work
chandran
et
al
subsequ
studi
kaletski
et
al
schornberg
et
al
suggest
zebovgp
activ
phdepend
cystein
proteas
cathepsin
b
l
term
cathepsin
bl
remaind
manuscript
upon
viral
entri
host
cell
endosom
addit
link
integrin
express
cathepsin
bl
activ
gpmediat
entri
reveal
schornberg
et
al
line
previou
report
indic
integrin
promot
ebovgpdepend
host
cell
entri
takada
et
al
howev
present
unclear
ebov
speci
marv
compar
depend
cathepsin
bl
activ
viral
entri
unknown
cathepsin
bl
activ
requir
gpdriven
entri
macrophag
central
target
cell
filovirus
cell
entri
sever
acut
respiratori
syndrom
coronaviru
sarscov
also
requir
activ
viral
envelop
protein
spike
cathepsin
b
l
simmon
et
al
howev
express
type
ii
transmembran
serin
proteas
ttsp
cellassoci
proteas
known
activ
influenza
viru
et
al
chaipan
et
al
human
metapneumoviru
shirogan
et
al
allow
cathepsin
blindepend
host
cell
entri
indic
sarscov
use
differ
proteas
ensur
activ
sprotein
glowacka
et
al
matsuyama
et
al
shulla
et
al
find
observ
express
type
ii
pneumocyt
major
viral
target
cell
glowacka
et
al
matsuyama
et
al
suggest
inhibit
cathepsin
bl
activ
might
appreci
reduc
viral
spread
infect
patient
whether
ttsp
also
cleav
activ
ebovgp
cathepsin
blindepend
host
cell
entri
unknown
show
depend
cathepsin
blactiv
entri
cell
conserv
gp
four
ebov
speci
modul
express
macrophag
infect
driven
differ
ebovgp
also
depend
cathepsin
bl
activ
line
find
made
cell
contrast
marvgpmedi
infect
exhibit
littl
depend
cathepsin
bl
activ
indic
marvgp
use
proteas
ensur
activ
order
assess
proteolyt
activ
ebovgp
cathepsin
b
l
select
panel
previous
character
commerci
avail
inhibitor
tabl
sever
inhibitor
determin
activ
cathepsin
b
l
cell
employ
inhibitor
concentr
subsequ
use
infect
experi
cathepsin
b
inhibitor
sigma
potent
block
cathepsin
b
activ
expect
concentr
also
reduc
cathepsin
l
activ
fig
deriv
high
membran
permeabl
calbiochem
exhibit
activ
similar
concentr
test
notabl
previous
shown
inhibit
cellular
entri
ecotrop
murin
leukemia
viru
via
inhibit
cathepsin
l
demonstr
modest
activ
cathepsin
l
fig
suffici
exert
antivir
effect
yoshii
et
al
cathepsin
l
inhibitor
iii
irrevers
inhibitor
cathepsin
l
merck
highli
activ
cathepsin
l
unexpectedli
also
inhibit
cathepsin
b
similar
effici
fig
aebsf
serin
proteas
inhibitor
roth
display
activ
cathepsin
b
l
cystein
proteas
inhibitor
sigma
fulli
inhibit
cathepsin
b
reduc
cathepsin
l
activ
half
appli
concentr
fig
none
inhibitor
test
activ
cathepsin
indic
substanti
level
select
although
inhibit
cystein
cathepsin
like
cathepsin
h
k
test
final
leupeptin
well
character
inhibitor
serin
cystein
proteas
aoyagi
et
al
mdl
effici
inhibitor
cathepsin
b
activ
mehdi
cathepsin
l
activ
simmon
et
al
sarss
driven
host
cell
entri
simmon
et
al
also
includ
panel
glycoprotein
ebola
viru
speci
depend
cathepsin
b
l
activ
host
cell
entri
cathepsin
b
l
previous
shown
activ
zebovgp
host
cell
entri
chandran
et
al
order
address
gp
differ
ebov
activ
differenti
host
cell
proteas
compar
activ
gp
deriv
zebov
rebov
exhibit
differenti
pathogen
human
feldmann
geisbert
employ
infectivitynorm
hivderiv
vector
pseudotyp
zebovand
rebovgp
infect
target
cell
either
pretreat
proteas
inhibitor
fig
gray
black
bar
inhibitor
solvent
control
white
bar
particl
bear
gp
fig
gprotein
vesicular
stomat
viru
vsvg
use
control
aebsf
treatment
target
cell
effect
entri
pseudotyp
test
fig
upper
panel
right
leupeptin
inhibit
zebovand
rebovgpdepend
entri
fig
upper
panel
left
indic
cystein
serin
proteas
involv
ebovgp
activ
inhibit
accord
distributor
inhibit
highest
concentr
test
fold
inhibit
highest
concentr
test
fold
inhibit
highest
concentr
test
inhibit
nd
done
zebovand
rebovgpdriven
entri
agreement
concept
cathepsin
bl
activ
ebovgp
fig
lower
panel
howev
rel
import
cathepsin
b
l
activ
glycoprotein
might
differ
sinc
cathepsin
l
inhibitor
iii
tabl
display
highest
activ
cathepsin
l
compound
test
inhibit
cell
entri
driven
zebovand
rebovgp
larg
cathepsin
bspecif
inhibitor
tabl
inhibit
entri
driven
gp
ebov
speci
although
differ
effici
fig
suggest
cathepsin
b
potenti
also
cathepsin
l
depend
host
cell
entri
conserv
ebovgp
sum
result
indic
effici
cellular
entri
driven
gp
ebov
speci
depend
activ
cathepsin
b
andor
l
rel
contribut
enzym
gp
activ
might
vari
ebov
speci
evid
marburg
viru
glycoprotein
activ
proteas
cathepsin
b
l
previou
studi
indic
replic
compet
marv
might
depend
cathepsin
bl
activ
host
cell
entri
sanchez
cellular
entri
lentivir
vector
pseudotyp
marvgp
show
variabl
depend
cathepsin
b
l
activ
appli
concentr
modestli
suppress
marvgpdriven
entri
cell
inhibit
data
shown
two
experi
appreci
effect
two
separ
experi
inhibit
fig
data
shown
result
suggest
marvgp
inde
less
depend
cathepsin
bl
activ
entri
cell
compar
ebovgp
howev
leupeptin
aebsf
robustli
invari
suppress
host
cell
entri
driven
marvgp
fig
demonstr
marvgp
like
ebovgp
depend
activ
host
cell
proteas
infecti
entri
natur
respons
proteas
remain
defin
sprotein
sarscov
also
activ
cathepsin
b
l
simmon
et
al
howev
depend
cathepsin
activ
markedli
reduc
target
cell
express
type
ii
transmembran
serin
proteas
glowacka
et
al
matsuyama
et
al
shulla
et
al
next
address
relat
proteas
hepsin
modul
cathepsindepend
ebovgp
host
cell
entri
coexpress
ebovgp
ctermin
tag
hepsin
cell
analyz
gp
cleavag
western
blot
gp
cleav
absenc
ttsp
express
fig
agreement
previous
publish
find
gp
proteolyt
process
furin
volchkov
et
al
ubiquit
express
preprotein
convertas
activ
cell
line
use
gp
express
present
studi
bush
et
al
yano
et
al
howev
cleavag
effici
differ
gp
analyz
zebovand
sebovgp
effici
cleav
cleavag
ciebovand
rebovgp
ineffici
fig
notabl
ineffici
cleavag
rebovgp
rescu
hepsin
coexpress
coexpress
allow
effici
cleavag
rebovand
ciebovgp
thu
hepsin
might
activ
rebovandor
ciebovgp
host
cell
entri
howev
coexpress
neither
proteas
viru
produc
cell
fig
viral
target
cell
fig
allow
effici
gpdriven
entri
cell
pretreat
cathepsin
bl
inhibitor
abl
partial
rescu
blockad
sarssdriven
infect
fig
expect
glowacka
et
al
matsuyama
et
al
shulla
et
al
result
suggest
hepsin
function
replac
cathepsin
bl
activ
ebov
target
cell
cathepsin
bl
activ
essenti
effici
ebola
marburg
viru
glycoproteindriven
entri
macrophag
previou
studi
role
cathepsin
proteolyt
activ
ebovgp
larg
focus
cell
line
chandran
et
al
schornberg
et
al
import
enzym
viral
entri
macrophag
key
target
cell
filoviru
infect
examin
incub
macrophag
leupeptin
inhibit
entri
driven
zebovand
rebovgp
vsvg
fig
contrast
leupeptin
effici
reduc
marvgpdepend
infect
fig
aebsf
effect
data
shown
indic
marv
might
employ
cellular
proteas
addit
instead
cathepsin
b
l
entri
macrophag
mani
virus
caus
diseas
human
includ
hiv
influenza
viru
sarscov
acquir
infect
upon
proteolyt
activ
glycoprotein
bertram
et
al
harrison
whether
hold
true
ebov
long
unclear
sinc
cleavag
furin
consensu
site
ebovgp
found
dispens
infect
neumann
et
al
neumann
et
al
schornberg
et
al
indic
proteolyt
activ
ebov
occur
upon
viral
uptak
host
cell
interestingli
proteolysi
gp
cathepsin
bl
seem
requir
engag
endosom
membran
protein
niemannpick
essenti
infecti
filoviru
entri
carett
et
al
cote
et
al
show
gp
ebov
subspeci
depend
cathepsin
bl
activ
viral
entri
cell
although
differ
degre
similarli
ebovgpdriven
infect
macrophag
requir
cathepsin
bl
activ
contrast
marvgpdriven
entri
larg
cathepsin
blindepend
promot
far
uncharacter
host
cell
proteas
final
hepsin
member
ttsp
famili
known
activ
sarscov
influenza
virus
et
al
glowacka
et
al
matsuyama
et
al
shulla
et
al
abl
cleav
ebovgp
unabl
support
gpdepend
cathepsin
blindepend
host
cell
entri
previou
studi
report
gp
four
ebov
subspeci
differ
interact
host
cell
instanc
zebovbut
rebovgp
found
interact
effici
dendrit
cell
lectin
hmgl
takada
et
al
express
zebovgp
rebov
shown
interfer
integr
blood
vessel
endothelium
yang
et
al
result
demonstr
gp
four
ebov
speci
depend
cathepsin
blactiv
host
cell
entri
sensit
zebovgp
inhibit
highest
gp
test
suggest
zebovgp
might
particularli
depend
activ
cathepsin
bl
need
note
activ
cathepsin
b
compar
cathepsin
l
highest
concentr
use
inhibitori
effect
observ
infect
experi
might
thu
mainli
stem
cathepsin
b
blockad
depend
individu
activ
cathepsin
b
cathepsin
l
might
vari
zebovand
rebovgp
latter
insensit
inhibit
sensit
blockad
cathepsin
l
inhibitor
iii
reason
differ
present
unknown
might
relat
differ
cathepsin
bl
target
site
cathepsin
l
cleavag
site
zebovgp
recent
propos
hood
et
al
sequenc
inde
differ
zebovand
rebovgp
moreov
wong
colleagu
select
ebovgp
variant
amino
acid
chang
allow
entri
cell
treat
cathepsin
b
inhibitor
respect
amino
acid
conserv
ebov
speci
wong
et
al
altern
gp
might
intrins
amen
proteolysi
other
might
thu
exhibit
differ
requir
cathepsin
activ
show
inhibit
cathepsin
bl
effici
block
zebov
marv
entri
vero
cell
although
inhibit
viral
replic
observ
sanchez
contrast
huang
colleagu
report
engin
express
cathepsin
l
murin
cathepsin
l
knockout
cell
increas
marvgpmedi
entri
huang
et
al
reason
discrep
result
present
unclear
observ
suggest
marv
either
requir
proteolyt
activ
gp
entri
marv
ebov
reli
differ
host
cell
proteas
ensur
activ
find
leupeptin
inhibitor
cystein
serin
proteas
block
marvgpdriven
entri
indic
latter
case
respons
proteas
remain
defin
mani
ttsp
play
import
role
cancer
develop
choi
et
al
recent
studi
demonstr
sever
protein
might
also
promot
viral
infect
facilit
activ
viral
glycoprotein
thu
shown
activ
influenza
viru
et
al
human
metapneumoviru
shirogan
et
al
sarscov
glowacka
et
al
matsuyama
et
al
shulla
et
al
latter
find
remark
previous
report
sarscov
reli
cathepsin
b
l
activ
simmon
et
al
observ
cathepsin
bldepend
abrog
suggest
virion
activ
contact
plasma
membran
target
cell
reach
endolysosom
contain
cathepsin
b
l
alreadi
activ
result
show
relat
proteas
hepsin
cleav
rebovandor
ciebovgp
potenti
site
furin
zebovgp
sebovgp
presum
also
cleav
cleavag
could
demonstr
effici
process
protein
endogen
furin
cell
woollewi
bate
howev
cleavag
hepsin
result
gp
activ
cathepsin
blindepend
cellular
entri
agreement
previou
find
indic
furin
cleavag
site
dispens
viral
spread
pathogen
neumann
et
al
neumann
et
al
thu
unlik
situat
note
sarscov
ttsp
unlik
rescu
ebov
antivir
effect
therapeut
appli
cathepsin
blinhibitor
macrophag
key
target
ebov
experiment
infect
anim
human
infect
believ
result
uncontrol
releas
cytokin
hallmark
ebov
diseas
feldmann
geisbert
hartman
et
al
zebovand
rebovgpdriven
entri
macrophag
depend
cathepsin
bl
activ
result
suggest
cathepsin
bl
inhibitor
could
display
antivir
activ
ebov
infect
individu
howev
recent
studi
suggest
zebovgpdriven
entri
dendrit
cell
target
zebov
geisbert
et
al
mahanti
et
al
requir
cathepsin
b
l
activ
martinez
et
al
find
combin
present
observ
blockad
ebovgpdepend
entri
cathepsin
inhibitor
frequent
incomplet
suggest
efficaci
inhibitor
need
improv
compar
present
avail
compound
order
achiev
profound
antivir
effect
effort
ongo
shah
et
al
sum
cathepsin
b
l
requir
effici
ebovbut
marvgpdriven
infect
cell
line
macrophag
cell
maintain
dmem
gibco
supplement
fetal
bovin
serum
fb
biochrom
penicillinstreptomycin
cell
glowacka
et
al
cell
cultur
similar
addit
zeocin
invitrogen
primari
human
monocytederiv
macrophag
cultur
monocyt
differenti
medium
xvivo
medium
lonza
supplement
human
fibrindeplet
plasma
penicillin
streptomycin
cell
grown
humidifi
atmospher
co
primari
human
monocytederiv
macrophag
prepar
buffi
coat
thrombocytedeplet
blood
collect
upon
ficol
densiti
gradient
centrifug
buffi
coat
wash
three
time
resuspens
icecold
pb
centrifug
rpm
cell
resuspend
ml
monocyt
adhes
medium
rpmi
paa
supplement
human
fibrindeplet
plasma
penicillinstreptomycin
seed
two
tissuecultur
dish
min
incub
nonadher
cell
remov
wash
cell
seven
time
ml
warm
pb
adher
cell
incub
ml
monocyt
adhes
medium
overnight
next
day
cell
wash
pb
detach
stempro
accutas
invitrogen
seed
plate
monocyt
differenti
macrophag
cultur
monocyt
differenti
medium
seven
day
express
plasmid
encod
glycoprotein
ebov
speci
zair
ebolaviru
sudan
ebolaviru
cote
divoir
ebolaviru
reston
ebolaviru
without
ctermin
well
marv
sarscoronaviru
vesicular
stomat
viru
vsv
describ
previous
hofmann
et
al
et
al
et
al
marzi
et
al
express
plasmid
proteas
hepsin
also
describ
previous
bertram
et
al
chaipan
et
al
shirogan
et
al
gener
human
immunodefici
viru
hiv
pseudotyp
plasmid
e
r
luc
employ
connor
et
al
detect
hepsinmedi
cleavag
ebovgp
cell
seed
plate
cotransfect
ebovgp
proteas
express
plasmid
employ
calcium
phosphat
transfect
medium
replac
fresh
cultur
medium
h
post
transfect
cell
lyse
h
post
transfect
protein
separ
sdspage
transfer
onto
nitrocellulos
membran
detect
use
mous
antibodi
invitrogen
load
control
detect
employ
mous
monoclon
antibodi
sigma
gener
pseudotyp
carri
differ
ebovgp
sarss
vsvg
glycoprotein
control
cell
calcium
phosphatecotransfect
dna
ratio
e
r
luc
glycoprotein
express
plasmid
empti
plasmid
tissu
cultur
flask
experi
addit
proteas
express
plasmid
cotransfect
medium
chang
h
post
transfect
h
post
transfect
supernat
harvest
pass
pores
filter
concentr
use
vivaspin
column
sartoriu
viru
stock
either
normal
equal
elisa
advanc
bioscienc
laboratori
compar
infect
cell
luciferas
assay
promega
infect
experi
cell
cell
seed
plate
densiti
cellswel
monocyt
seed
differenti
plate
densiti
cellswel
infect
latest
day
addit
differenti
medium
cell
infect
infectivitynorm
viru
cell
macrophag
infect
spinocul
odoherti
et
al
rpm
h
medium
exchang
h
post
infect
infect
measur
determin
luciferas
activ
cell
lysat
h
post
infect
use
commerci
avail
kit
promega
determin
inhibitor
specif
cell
seed
treat
proteas
inhibitor
describ
infect
experi
h
cell
wash
pb
lyse
cathepsin
b
l
merck
anaspec
activ
cell
lysat
measur
use
commerci
avail
kit
accord
manufactur
instruct
proteas
inhibitor
calbiochem
aebsf
roth
cathepsin
l
inhibitor
iii
merck
leupeptin
sigma
dilut
pb
use
indic
concentr
proteas
inhibit
target
cell
pretreat
indic
inhibitor
min
infect
infectivitynorm
pseudotyp
presenc
inhibitor
inhibitor
contain
medium
replac
fresh
cultur
medium
without
inhibitor
h
post
infect
